Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Sulamserod

Copy Product Info
😃Good
Catalog No. T13021Cas No. 219757-90-1
Alias RS-100302

Sulamserod (RS 100302) is a potent 5-HT4 receptor antagonist with antiarrhythmic activity for the study of atrial fibrillation and cardiovascular related diseases.

Sulamserod

Sulamserod

Copy Product Info
😃Good
Purity: 98.76%
Catalog No. T13021Alias RS-100302Cas No. 219757-90-1
Sulamserod (RS 100302) is a potent 5-HT4 receptor antagonist with antiarrhythmic activity for the study of atrial fibrillation and cardiovascular related diseases.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$545-In Stock
5 mg$1,190-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.76%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Sulamserod (RS 100302) is a potent 5-HT4 receptor antagonist with antiarrhythmic activity for the study of atrial fibrillation and cardiovascular related diseases.
In vivo
In pigs, the administration of Sulamserod at a dose of 30 mg/kg results in significant effects on electrophysiological parameters. Specifically, Sulamserod prolongs the mean effective refractory period (ERP) (14667 ms versus 11568 ms, P < 0.01) and wavelength (9.960.8 cm versus 8.360.9 cm, P < 0.01). Additionally, it reduces the dispersion of ERP (861 ms versus 1565 ms, P < 0.01) and causes a minimal slowing of conduction velocity (6765 cm/s versus 7264 cm/s, P < 0.01).
Notably, Sulamserod does not induce any ventricular electrophysiological effects. Moreover, its administration leads to the termination of atrial flutter in 6 out of 8 animals and atrial fibrillation in 8 out of 9 animals. Furthermore, Sulamserod effectively prevents the reinduction of sustained tachycardia in all animals[1].
SynonymsRS-100302
Chemical Properties
Molecular Weight445.96
FormulaC19H28ClN3O5S
Cas No.219757-90-1
SmilesO=C(C1=CC(Cl)=C(N)C=2OCCOC21)CCC3CCN(CCNS(=O)(=O)C)CC3
Relative Density.1.319 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Sulamserod | purchase Sulamserod | Sulamserod cost | order Sulamserod | Sulamserod chemical structure | Sulamserod in vivo | Sulamserod formula | Sulamserod molecular weight